BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,511,000 | -32.8% | 50,000 | -32.4% | 0.04% | -25.5% |
| Q2 2022 | $3,738,000 | -30.2% | 74,000 | +48.0% | 0.05% | -15.0% |
| Q4 2021 | $5,354,000 | -4.1% | 50,000 | -7.9% | 0.06% | -6.2% |
| Q3 2021 | $5,581,000 | +334.0% | 54,291 | +146.8% | 0.06% | -12.3% |
| Q1 2020 | $1,286,000 | -93.4% | 22,000 | -91.8% | 0.07% | -92.9% |
| Q3 2019 | $19,624,000 | +65.2% | 267,100 | +112.2% | 1.02% | +70.7% |
| Q2 2019 | $11,876,000 | +724.1% | 125,900 | +599.4% | 0.60% | +657.0% |
| Q1 2019 | $1,441,000 | – | 18,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |